{"id":"https://openalex.org/W4244879377","doi":"https://doi.org/10.36488//cmac.2020.2.119-127","title":"Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients","display_name":"Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W4244879377","doi":"https://doi.org/10.36488//cmac.2020.2.119-127"},"language":"en","primary_location":{"id":"doi:10.36488//cmac.2020.2.119-127","doi":"https://doi.org/10.36488//cmac.2020.2.119-127","is_oa":true,"landing_page_url":"https://doi.org/10.36488//cmac.2020.2.119-127","pdf_url":"https://cmac-journal.ru/en/publication/2020/2/cmac-2020-t22-n2-p119/cmac-2020-t22-n2-p119.pdf","source":{"id":"https://openalex.org/S4210237225","display_name":"Clinical Microbiology and Antimicrobial Chemotherapy","issn_l":"1684-4386","issn":["1684-4386","2686-9586"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","erih-plus","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Microbiology and Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://cmac-journal.ru/en/publication/2020/2/cmac-2020-t22-n2-p119/cmac-2020-t22-n2-p119.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026307466","display_name":"\u041d. \u041d. \u0414\u0435\u0445\u043d\u0438\u0447","orcid":"https://orcid.org/0000-0002-6144-3919","observed_orcids":["https://orcid.org/0000-0002-6144-3919"]},"institutions":[{"id":"https://openalex.org/I4210120801","display_name":"Smolensk State Medical University","ror":"https://ror.org/02wwnew71","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210120801"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Natalya N. Dekhnich","raw_affiliation_strings":["Smolensk State Medical University; Institute of Antimicrobial Chemotherapy, Smolensk, Russia","Smolensk State Medical University, Smolensk, RussiaInstitute of Antimicrobial Chemotherapy, Smolensk, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Smolensk State Medical University; Institute of Antimicrobial Chemotherapy, Smolensk, Russia","institution_ids":["https://openalex.org/I4210120801"]},{"raw_affiliation_string":"Smolensk State Medical University, Smolensk, RussiaInstitute of Antimicrobial Chemotherapy, Smolensk, Russia","institution_ids":["https://openalex.org/I4210120801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072175554","display_name":"\u0422\u0440\u044f\u043f\u044b\u0448\u043a\u043e \u0410\u043d\u0434\u0440\u0435\u0439 \u0410\u043d\u0434\u0440\u0435\u0435\u0432\u0438\u0447","orcid":"https://orcid.org/0000-0003-4652-8161","observed_orcids":["https://orcid.org/0000-0003-4652-8161"]},"institutions":[{"id":"https://openalex.org/I4210120801","display_name":"Smolensk State Medical University","ror":"https://ror.org/02wwnew71","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210120801"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A.A. Tryapyshko","raw_affiliation_strings":["Smolensk State Medical University, Smolensk, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Smolensk State Medical University, Smolensk, Russia","institution_ids":["https://openalex.org/I4210120801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073488504","display_name":"Ivan V. Trushin","orcid":"https://orcid.org/0000-0003-0128-1839","observed_orcids":["https://orcid.org/0000-0003-0128-1839"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ivan V. Trushin","raw_affiliation_strings":["Institute of Antimicrobial Chemotherapy, Smolensk, Russia"],"raw_orcid":"https://orcid.org/0000-0003-0128-1839","affiliations":[{"raw_affiliation_string":"Institute of Antimicrobial Chemotherapy, Smolensk, Russia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052565506","display_name":"Alexey Yu. Kuzmenkov","orcid":"https://orcid.org/0000-0001-9562-2096","observed_orcids":["https://orcid.org/0000-0001-9562-2096"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Alexey Yu. Kuzmenkov","raw_affiliation_strings":["Institute of Antimicrobial Chemotherapy, Smolensk, Russia"],"raw_orcid":"https://orcid.org/0000-0001-9562-2096","affiliations":[{"raw_affiliation_string":"Institute of Antimicrobial Chemotherapy, Smolensk, Russia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029139734","display_name":"Roman Sergeevich Kozlov","orcid":"https://orcid.org/0000-0001-8728-1113","observed_orcids":["https://orcid.org/0000-0001-8728-1113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roman S. Kozlov","raw_affiliation_strings":["Institute of Antimicrobial Chemotherapy, Smolensk, Russia"],"raw_orcid":"https://orcid.org/0000-0001-8728-1113","affiliations":[{"raw_affiliation_string":"Institute of Antimicrobial Chemotherapy, Smolensk, Russia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5052565506"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5341,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.62933892,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"22","issue":"2","first_page":"119","last_page":"127"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/helicobacter-pylori-eradication","display_name":"Helicobacter pylori eradication","score":0.8769999742507935},{"id":"https://openalex.org/keywords/nifuratel","display_name":"nifuratel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/clarithromycin","display_name":"clarithromycin","score":0.9010000228881836},{"id":"https://openalex.org/keywords/esomeprazole","display_name":"esomeprazole","score":0.8389999866485596},{"id":"https://openalex.org/keywords/amoxicillin","display_name":"amoxicillin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dyspepsia","display_name":"dyspepsia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5789999961853027},{"id":"https://openalex.org/keywords/stool-antigen-test","display_name":"stool antigen test","score":0.8730000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7992109060287476},{"id":"https://openalex.org/C2778204628","wikidata":"https://www.wikidata.org/wiki/Q553223","display_name":"Esomeprazole","level":2,"score":0.7664215564727783},{"id":"https://openalex.org/C2776962512","wikidata":"https://www.wikidata.org/wiki/Q118551","display_name":"Clarithromycin","level":3,"score":0.7625093460083008},{"id":"https://openalex.org/C2779708577","wikidata":"https://www.wikidata.org/wiki/Q201928","display_name":"Amoxicillin","level":3,"score":0.75281822681427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.751073956489563},{"id":"https://openalex.org/C2776409635","wikidata":"https://www.wikidata.org/wiki/Q180556","display_name":"Helicobacter pylori","level":2,"score":0.5742119550704956},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5555477738380432},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5217762589454651},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.482394814491272},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4470489025115967},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4164820909500122},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.16563868522644043},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.07075202465057373},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.36488//cmac.2020.2.119-127","doi":"https://doi.org/10.36488//cmac.2020.2.119-127","is_oa":true,"landing_page_url":"https://doi.org/10.36488//cmac.2020.2.119-127","pdf_url":"https://cmac-journal.ru/en/publication/2020/2/cmac-2020-t22-n2-p119/cmac-2020-t22-n2-p119.pdf","source":{"id":"https://openalex.org/S4210237225","display_name":"Clinical Microbiology and Antimicrobial Chemotherapy","issn_l":"1684-4386","issn":["1684-4386","2686-9586"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","erih-plus","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Microbiology and Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"doi:10.36488/cmac.2020.2.119-127","doi":"https://doi.org/10.36488/cmac.2020.2.119-127","is_oa":true,"landing_page_url":"https://doi.org/10.36488/cmac.2020.2.119-127","pdf_url":null,"source":{"id":"https://openalex.org/S4210237225","display_name":"Clinical Microbiology and Antimicrobial Chemotherapy","issn_l":"1684-4386","issn":["1684-4386","2686-9586"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","erih-plus","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Microbiology and Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:9c49d8bdea1b4476b1df3cac03646d56","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9c49d8bdea1b4476b1df3cac03646d56","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043c\u0438\u043a\u0440\u043e\u0431\u0438\u043e\u043b\u043e\u0433\u0438\u044f \u0438 \u0430\u043d\u0442\u0438\u043c\u0438\u043a\u0440\u043e\u0431\u043d\u0430\u044f \u0445\u0438\u043c\u0438\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f, Vol 22, Iss 2, Pp 119-127 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.36488//cmac.2020.2.119-127","doi":"https://doi.org/10.36488//cmac.2020.2.119-127","is_oa":true,"landing_page_url":"https://doi.org/10.36488//cmac.2020.2.119-127","pdf_url":"https://cmac-journal.ru/en/publication/2020/2/cmac-2020-t22-n2-p119/cmac-2020-t22-n2-p119.pdf","source":{"id":"https://openalex.org/S4210237225","display_name":"Clinical Microbiology and Antimicrobial Chemotherapy","issn_l":"1684-4386","issn":["1684-4386","2686-9586"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","erih-plus","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Microbiology and Antimicrobial Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4244879377.pdf","grobid_xml":"https://content.openalex.org/works/W4244879377.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1965464610","https://openalex.org/W1997857676","https://openalex.org/W2039745983","https://openalex.org/W2050204863","https://openalex.org/W2059363101","https://openalex.org/W2084612599","https://openalex.org/W2100000977","https://openalex.org/W2111942462","https://openalex.org/W2133779988","https://openalex.org/W2136210283","https://openalex.org/W2157471555","https://openalex.org/W2183787411","https://openalex.org/W2199230185","https://openalex.org/W2254794399","https://openalex.org/W2337046476","https://openalex.org/W2401076609","https://openalex.org/W3123026253","https://openalex.org/W4248904055"],"related_works":["https://openalex.org/W4290000576","https://openalex.org/W4293110090","https://openalex.org/W2354863266","https://openalex.org/W2754060329","https://openalex.org/W2356529634","https://openalex.org/W2109291983","https://openalex.org/W2089806224","https://openalex.org/W7098627581","https://openalex.org/W2355438421","https://openalex.org/W2011804255"],"abstract_inverted_index":{"Objective.":[0],"To":[1],"assess":[2],"efficacy":[3],"and":[4,26,35,70,95,118,130,145,163],"safety":[5],"of":[6,30,101,157,165,208],"14-day":[7,13,58,82,114,119,176],"triple":[8,15,59,85,116,121,177,191,201],"nifuratel-based":[9,60,115,178],"therapy":[10,16,117,122,179,192,202],"compared":[11],"to":[12,199],"standard":[14],"in":[17,123,155,159,167],"adult":[18],"patients":[19,32,158,166,204],"with":[20,33,205],"symptomatic":[21],"H.":[22,38,102,184],"pylori":[23,39,103,185],"infection.":[24],"Materials":[25],"Methods.":[27],"A":[28],"total":[29],"70":[31],"dyspepsia":[34],"microbiologically":[36],"confirmed":[37],"infection":[40],"were":[41,128,143,153],"enrolled":[42],"into":[43],"the":[44,124,137,160,168,209],"open-label,":[45],"randomized,":[46],"comparative":[47],"clinical":[48],"trial.":[49],"The":[50,75,175],"study":[51,161],"group":[52,77,162,170],"(n":[53,78],"=":[54,79,133,148],"35)":[55,80],"received":[56,81],"a":[57,182,206],"therapy:":[61,86],"esomeprazole":[62,87],"(20":[63,88],"mg":[64,68,73,89,93,98],"BID),":[65,90],"nifuratel":[66],"(400":[67],"BID)":[69,94],"amoxicillin":[71,96],"(1000":[72,97],"BID).":[74,99],"comparator":[76,169],"conventional":[83],"clarithromycinbased":[84],"clarithromycin":[91],"(500":[92],"Eradication":[100,111],"was":[104],"assessed":[105],"using":[106],"stool":[107],"antigen":[108],"test.":[109],"Results.":[110],"rates":[112,142],"for":[113,203],"clarithromycin-based":[120,200],"intent-to-treat":[125],"(ITT)":[126],"population":[127],"82.9%":[129],"74.3%":[131],"(p":[132,147,171],"0.561),":[134],"respectively.":[135,150],"In":[136],"per-protocol":[138],"(PP)":[139],"population,":[140],"eradication":[141,186],"90.6%":[144],"89.7%":[146],"1.00),":[149],"Adverse":[151],"events":[152],"reported":[154],"17.1%":[156],"34.3%":[164],">":[172],"0.05).":[173],"Conclusions.":[174],"has":[180],"demonstrated":[181],"high":[183],"rate":[187],"(above":[188],"90%).":[189],"Nifuratel":[190],"may":[193],"be":[194],"considered":[195],"as":[196],"an":[197],"alternative":[198],"history":[207],"prior":[210],"macrolide":[211,214],"exposure":[212],"or":[213],"intolerance.":[215]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2022-05-12T00:00:00"}